RETRACTION: Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways (Retraction of Vol 24, Pg 7295, 2018)
An editorial decision has been made to retract this manuscript due to breach of publishing guidelines, following the identification of non-original and manipulated figures. Reference: Liu Li, Lu Huizhi, Wang Binu, Deng Xinxin, Wu Longjun, Yang Liping, Zhang Yingying. Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways. Med Sci Monit, 2018; 24: 7295-7302. DOI: 10.12659/MSM.910702.
第一作者机构：[1]Wuhan Univ, Wuhan Hosp 3, Tongren Hosp, Dept Ear Nose & Throat ENT, Wuhan, Hubei, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Liu Li,Lu Huizhi,Wang Binu,et al.RETRACTION: Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways (Retraction of Vol 24, Pg 7295, 2018)[J].MEDICAL SCIENCE MONITOR.2022,28:doi:10.12659/MSM.937840.
APA：
Liu Li,Lu Huizhi,Wang Binu,Deng Xinxin,Wu Longjun...&Zhang Yingying.(2022).RETRACTION: Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways (Retraction of Vol 24, Pg 7295, 2018).MEDICAL SCIENCE MONITOR,28,
MLA：
Liu Li,et al."RETRACTION: Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways (Retraction of Vol 24, Pg 7295, 2018)".MEDICAL SCIENCE MONITOR 28.(2022)
